Comparable Ten-Year Outcome in Hemodialysis Patients with Hepatitis C Virus and Hepatitis B Virus Coinfection and Single Hepatitis B Virus Infection

被引:3
作者
Lee, Cheng-Chia [1 ,2 ]
Li, I-Jung [1 ,2 ,3 ]
Chen, Yung-Chang [1 ,2 ]
Cheng, Jen-Wei [1 ,2 ]
Wu, Hsin-Hsu [1 ,2 ,3 ]
Weng, Cheng-Hao [1 ,2 ,3 ]
Fang, Ji-Tseng [1 ,2 ]
Tian, Ya-Chung [1 ,2 ]
机构
[1] Lin Kou Chang Gung Mem Hosp, Dept Nephrol, Taipei 105, Taiwan
[2] Chang Gung Univ, Dept Med, Tao Yuan, Taiwan
[3] Chang Gung Univ, Grad Inst Clin Med Sci, Tao Yuan, Taiwan
关键词
Hepatitis B virus; Hepatitis C virus; Coinfection; Hemodialysis; CHRONIC-RENAL-FAILURE; DIALYSIS PATIENTS; HEPATOCELLULAR-CARCINOMA; VIRAL-HEPATITIS; DUAL INFECTION; PREVALENCE; DISEASE; TAIWAN; IMPACT; SUPERINFECTION;
D O I
10.1159/000324196
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection in comparison with single HBV infection causes more severe liver disease in nonuremic population. The long-term impact of HBV/HCV coinfection on severity of liver diseases and patient survival in hemodialysis patients is unclear. Forty-eight HBV-positive patients and 19 HBV/HCV-positive patients were followed up from February 1996 to September 2006. During 10-year follow-up, there was no difference in acute hepatitis episodes, abnormal serum alanine aminotransferase period, occurrence of cirrhosis and hepatocellular carcinoma, and patient survival between the two groups. The serum HBV DNA levels in HBV/HCV-positive patients were significantly lower than those in HBV-positive patients during the first 27-month follow-up. In conclusion, HCV infection suppresses the serum HBV DNA level in hemodialysis patients. Nevertheless, HBV/HCV coinfection in comparison with single HBV infection does not cause more severe liver diseases or reduce patient survival in hemodialysis patients ;during 10-year follow-up. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:89 / 95
页数:7
相关论文
共 38 条
[1]  
BENVEGNU L, 1994, CANCER, V74, P2442, DOI 10.1002/1097-0142(19941101)74:9<2442::AID-CNCR2820740909>3.0.CO
[2]  
2-#
[3]   Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants [J].
Chen, Chien-Hung ;
Yang, Pei-Ming ;
Huang, Guan-Tarn ;
Lee, Hsuan-Shu ;
Sung, Juei-Low ;
Sheu, Jin-Chuan .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2007, 106 (02) :148-155
[4]  
Chen KS, 1996, NEPHRON, V73, P158
[5]   Hepatitis B virus-related cirrhosis: Natural history and treatment [J].
Chu, CM ;
Liaw, YF .
SEMINARS IN LIVER DISEASE, 2006, 26 (02) :142-152
[6]   Characteristics of hepatitis C in renal transplant candidates [J].
Cotler, SJ ;
Diaz, G ;
Gundlapalli, S ;
Jakate, S ;
Chawla, A ;
Mital, D ;
Jensik, S ;
Jensen, DM .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2002, 35 (02) :191-195
[7]  
CRESPO J, 1994, AM J GASTROENTEROL, V89, P1147
[8]  
Espinosa M, 2000, CLIN NEPHROL, V54, P151
[9]  
Fabrizi F, 2004, G Ital Nefrol, V21, P21
[10]   The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies [J].
Fabrizi, F. ;
Takkouche, B. ;
Lunghi, G. ;
Dixit, V. ;
Messa, P. ;
Martin, P. .
JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) :697-703